{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:13:25Z","timestamp":1783710805543,"version":"3.55.0"},"reference-count":35,"publisher":"Xia & He Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,28]]},"DOI":"10.14218\/jcth.2018.00048","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T21:04:52Z","timestamp":1561496692000},"page":"1-5","source":"Crossref","is-referenced-by-count":1,"title":["Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese Population"],"prefix":"10.14218","volume":"7","author":[{"given":"Haruka","family":"Hirono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Ohkoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"key20190625210445_b1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"key20190625210445_b2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"key20190625210445_b3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ajg.2017.5","article-title":"Prevalence of nonalcoholic steatohepatitis-associated cirrhosis in the United States: An analysis of national health and nutrition examination survey data","volume":"112","author":"Kabbany","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"key20190625210445_b4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20190625210445_b5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"key20190625210445_b6","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"key":"key20190625210445_b7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2013.12.018","article-title":"Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations","volume":"60","author":"de L\u00e9dinghen","year":"2014","journal-title":"J Hepatol"},{"key":"key20190625210445_b8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4254\/wjh.v7.i4.638","article-title":"Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease","volume":"7","author":"Papagianni","year":"2015","journal-title":"World J Hepatol"},{"key":"key20190625210445_b9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12072-016-9772-z","article-title":"Non-invasive diagnosis of hepatic steatosis","volume":"11","author":"Stern","year":"2017","journal-title":"Hepatol Int"},{"key":"key20190625210445_b10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21520","article-title":"FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C","volume":"45","author":"Koda","year":"2007","journal-title":"Hepatology"},{"key":"key20190625210445_b11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20190625210445_b12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"key20190625210445_b13","doi-asserted-by":"crossref","first-page":"10851","DOI":"10.3748\/wjg.v20.i31.10851","article-title":"Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future","volume":"20","author":"Fitzpatrick","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20190625210445_b14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00535-014-1007-2","article-title":"Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease","volume":"50","author":"Abe","year":"2015","journal-title":"J Gastroenterol"},{"key":"key20190625210445_b15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/srep01065","article-title":"A serum \u201csweet-doughnut\u201d protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis","volume":"3","author":"Kuno","year":"2013","journal-title":"Sci Rep"},{"key":"key20190625210445_b16","doi-asserted-by":"crossref","first-page":"e0174982","DOI":"10.1371\/journal.pone.0174982","article-title":"Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease","volume":"12","author":"Lai","year":"2017","journal-title":"PLoS One"},{"key":"key20190625210445_b17","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.27305","article-title":"Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients","volume":"60","author":"Yamasaki","year":"2014","journal-title":"Hepatology"},{"key":"key20190625210445_b18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.dld.2007.10.019","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Yoneda","year":"2008","journal-title":"Dig Liver Dis"},{"key":"key20190625210445_b19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/hepr.12388","article-title":"Measurement of liver stiffness as a non-invasive method for diagnosis of non-alcoholic fatty liver disease","volume":"45","author":"Yoshioka","year":"2015","journal-title":"Hepatol Res"},{"key":"key20190625210445_b20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"key20190625210445_b21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3349\/ymj.2016.57.4.885","article-title":"The relationship between type 2 diabetes mellitus and non-alcoholic fatty liver disease measured by controlled attenuation parameter","volume":"57","author":"Chon","year":"2016","journal-title":"Yonsei Med J"},{"key":"key20190625210445_b22","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/jgh.13219","article-title":"Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease","volume":"31","author":"de L\u00e9dinghen","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"key20190625210445_b23","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/hepr.12094","article-title":"Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases","volume":"43","author":"Masaki","year":"2013","journal-title":"Hepatol Res"},{"key":"key20190625210445_b24","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/ajg.2017.389","article-title":"Prognostic value of controlled attenuation parameter by transient elastography","volume":"112","author":"Liu","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"key20190625210445_b25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12876-017-0617-6","article-title":"Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter","volume":"17","author":"Ferraioli","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"key20190625210445_b26","doi-asserted-by":"crossref","first-page":"e0157358","DOI":"10.1371\/journal.pone.0157358","article-title":"Discrimination of nonalcoholic steatohepatitis using transient elastography in patients with nonalcoholic fatty liver disease","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"key20190625210445_b27","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2337\/dc15-0140","article-title":"Independent association between improvement of nonalcoholic fatty liver disease and reduced incidence of type 2 diabetes","volume":"38","author":"Yamazaki","year":"2015","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"key20190625210445_b28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1440-1746.2010.06547.x","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan","volume":"26","author":"Okanoue","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"key20190625210445_b29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.endinu.2017.12.011","article-title":"Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes","volume":"65","author":"Aller de la Fuente","year":"2018","journal-title":"Endocrinol Diabetes Nutr"},{"key":"key20190625210445_b30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.25772","article-title":"Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology"},{"key":"key20190625210445_b31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2016.04.023","article-title":"Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease","volume":"65","author":"Boursier","year":"2016","journal-title":"J Hepatol"},{"key":"key20190625210445_b32","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.28843","article-title":"Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values","volume":"65","author":"Petta","year":"2017","journal-title":"Hepatology"},{"key":"key20190625210445_b33","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.3748\/wjg.v22.i32.7236","article-title":"Transient elastography (FibroScan(\u00ae)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?","volume":"22","author":"Mikolasevic","year":"2016","journal-title":"World J Gastroenterol"},{"key":"key20190625210445_b34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/hepr.12710","article-title":"Classification of patients with non-alcoholic fatty liver disease using rapid immunoassay of serum type IV collagen compared with liver histology and other fibrosis markers","volume":"47","author":"Mizuno","year":"2017","journal-title":"Hepatol Res"},{"key":"key20190625210445_b35","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/hepr.12662","article-title":"Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level in non-alcoholic steatohepatitis","volume":"46","author":"Nishikawa","year":"2016","journal-title":"Hepatol Res"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.xiahepublishing.com\/2310-8819\/ArticleFullText.aspx?sid=2&id=10.14218%2fJCTH.2018.00048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:17:34Z","timestamp":1783707454000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.xiahepublishing.com\/2310-8819\/ArticleFullText.aspx?sid=2&id=10.14218%2fJCTH.2018.00048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,6,25]]},"published-print":{"date-parts":[[2019,6,28]]}},"alternative-id":["10.14218\/JCTH.2018.00048"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2018.00048","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]}}}